Back
Elite Pharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Buy
54
ELTP
Elite Pharmaceuticals
Last Price:
0.62
Seasonality Move:
11.38%
Sell
32
VRCA
Verrica Pharmaceuticals
Last Price:
1.00
Seasonality Move:
50.34%
Buy
54
Elite Pharmaceuticals (ELTP)
is a Buy
Is Elite Pharmaceuticals a Buy, Sell or Hold?
- The current Elite Pharmaceuticals [ELTP] share price is $0.62. The Score for ELTP is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ELTP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ELTP Stock Price Chart
What is Elite Pharmaceuticals's stock price today?
-
The Elite Pharmaceuticals share price today is $0.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELTP is experiencing slight selling pressure.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.
ELTP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.29 | Buy |
| Chaikin Money Flow: | -1477660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.48 - 0.62) | Buy |
| Bollinger Bands (100): | (0.2 - 0.5) | Buy |
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 42.5 | Sell |
| Chaikin Money Flow: | 467298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.84 - 1.54) | Sell |
| Bollinger Bands (100): | (0.73 - 5.79) | Sell |
ELTP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Buy |
| 20-day SMA: | 0.55 | Buy |
| 50-day SMA: | 0.48 | Buy |
| 200-day SMA: | 0.25 | Buy |
| 8-day EMA: | 0.61 | Buy |
| 20-day EMA: | 0.56 | Buy |
| 50-day EMA: | 0.48 | Buy |
| 200-day EMA: | 0.3 | Buy |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.89 | Buy |
| 20-day SMA: | 1.09 | Sell |
| 50-day SMA: | 1.38 | Sell |
| 200-day SMA: | 5.03 | Sell |
| 8-day EMA: | 0.92 | Buy |
| 20-day EMA: | 1.06 | Sell |
| 50-day EMA: | 1.65 | Sell |
| 200-day EMA: | 4.01 | Sell |
Elite Pharmaceuticals Earnings Growth & ELTP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Elite Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verrica Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||